Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent Development—A Comprehensive Review
Diagnostics · 18.06.2024 · 14 (12) · 1289
DOI: 10.3390/diagnostics14121289 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 18.06.2024. Verfasst von Marianna Franchina und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neuroendocrine neoplasms (NENs) are a heterogeneous group of neoplasms presenting unique challenges in diagnosis and management. Traditional markers such as chromogranin A (CgA), pancreatic polypeptide (PP), and neuron-specific enolase (NSE) have limitations in terms of specificity and sensitivity. Specific circulating markers such as serotonin and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) and various gastrointestinal hormones such as gastrin, glucagon, somatostatin, and vasoactive intestinal peptide (VIP) have a role in identifying functional NENs. Recent advances in molecular and biochemical markers, also accounting for novel genomic and proteomic markers, have significantly improved the landscape for the diagnosis and monitoring of NENs. This review discusses these developments, focusing on both traditional markers such as CgA and NSE, as well as specific hormones like gastrin, insulin, somatostatin, glucagon, and VIP. Additionally, it covers emerging genomic and proteomic markers that are shaping current research. The clinical applicability of these markers is highlighted, and their role in improving diagnostic accuracy, predicting surgical outcomes, and monitoring response to treatment is demonstrated. The review also highlights the need for further research, including validation of these markers in larger studies, development of standardized assays, and integration with imaging techniques. The evolving field of biochemical markers holds promise for improving patient outcomes in the treatment of NENs, although challenges in standardization and validation remain.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
- Gastroenterology and Digestive Endoscopy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
- Department of Medicine and Surgery, University of Milano-Bicocca, 20126 Milan, Italy.
ORCID-Profile: Marianna Franchina, Federica Cavalcoli, Sara Massironi
Zitieren
APA
Franchina, M., Cavalcoli, F., Falco, O., La Milia, M., Elvevi, A., & Massironi, S. (2024). Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent Development—A Comprehensive Review. Diagnostics, 14(12), 1289. https://doi.org/10.3390/diagnostics14121289
Vancouver
Franchina M, Cavalcoli F, Falco O, La Milia M, Elvevi A, Massironi S. Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent Development—A Comprehensive Review. Diagnostics. 2024;14(12):1289. doi:10.3390/diagnostics14121289
BibTeX
@article{Franchina2024,
author = {Franchina, Marianna and Cavalcoli, Federica and Falco, Olga and La Milia, Marta and Elvevi, Alessandra and Massironi, Sara},
title = {Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent Development—A Comprehensive Review},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {12},
pages = {1289},
doi = {10.3390/diagnostics14121289}
}
EUVIMED